Navigation Links
Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine
Date:6/11/2008

is, Merck & Co., Inc., Wyeth, Sanofi Pasteur, Kirin, and the Statens Serum Institut.

The Company's leading product, a prophylactic vaccine against Japanese Encephalitis, successfully concluded pivotal Phase III clinical trials in 2006. The Market Authorization Application (MAA) in Europe as well as the Biological License Application (BLA) with the US Food and Drug Administration (FDA) for the use of the vaccine to prevent Japanese Encephalitis were submitted in December of 2007. The licensure application to TGA (Therapeutic Goods Administration) in Australia was submitted in February of 2008.

The Company's broad development pipeline includes a partnered S. aureus vaccine in Phase II, a therapeutic vaccine against Hepatitis C in Phase II, a Pseudomonas vaccine in Phase II, a partnered Tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development.

Intercell is listed on the Prime Market of the Vienna Stock Exchange under the symbol "ICLL".
ISIN: AT0000612601

For more information on Intercell, please visit: http://www.intercell.com

Important Additional Information Regarding the Proposed Merger

In connection with the proposed transaction, on May 14, 2008, Iomai Corporation filed a preliminary proxy statement for its stockholders with the Securities and Exchange Commission (SEC). Iomai Corporation will be filing a definitive proxy statement for its stockholders and other documents regarding the proposed transaction with the SEC. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, IOMAI STOCKHOLDERS AND INVESTORS ARE URGED TO CAREFULLY READ THE PRELIMINARY PROXY STATEMENT AND, WHEN IT BECOMES AVAILABLE, THE DEFINITIVE PROXY STATEMENT AS WELL AS ANY OTHER RELEVANT MATERIALS, IN THEIR ENTIRETY BECAUSE THE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND IOMAI. Investors and stockholders may obtai
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
5. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
6. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
7. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 25, 2015 Research and Markets ... addition of the "2015 Strategies in the ... offering. This comprehensive five-country report contains ... help current suppliers and potential market entrants identify ... coagulation testing market during the next five years. ...
(Date:5/27/2015)... Va. , May 27, 2015  Virginia Women,s ... practice to resolve vaginal health issues often caused by ... painless and requires no anesthesia, received FDA clearance in ... one of the first practices in Virginia ... laser specifically designed to help postmenopausal women as ...
(Date:5/27/2015)... LONDON and NEW YORK ... - http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html - Over 70% Indonesian ... Around 400,000 Indonesians die annually due to smoking-related conditions; ... Three-fourths of 6.5 million vehicles in Jakarta ... Indonesia is the fourth ...
Breaking Medicine Technology:European Coagulation Testing Market Strategies 2015 2Virginia Women's Center Welcomes The Newest Breakthrough In Women's Health Treatment 2Virginia Women's Center Welcomes The Newest Breakthrough In Women's Health Treatment 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4
... PARK, Ill., and WATERTOWN, Mass., Feb. 18 ... announced today the advancement,of their Hepatitis C (HCV) ... protease inhibitor for the treatment of chronic,HCV. ... safety, tolerability,and pharmacokinetics. ABT-450 was discovered as ...
... United States, fifth hand transplant recipient, Jan "Erik" ... York this week after a three-month stay in ... University of Louisville surgeons. (Photo: ... the Hondusky,s hand transplant at Louisville,s Jewish Hospital ...
Cached Medicine Technology:Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor 2Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor 3Fifth U.S. Hand Transplant Patient Heads Home to NY 2Fifth U.S. Hand Transplant Patient Heads Home to NY 3
(Date:5/27/2015)... Coco Libre announced today that artists and audiences ... Organic Coconut Water to quench their thirst during the festival ... areas, artist greenrooms, corporate skyboxes and concessions areas at the ... on festival shuttle buses. , “We’re excited to have ... Director of Strategic Partnerships for Latitude 38 Entertainment, producer of ...
(Date:5/27/2015)... Cincinnati, Ohio (PRWEB) May 27, 2015 Cincinnati ... Education & Research for Veterans (CERV) Foundation is proud to ... information fair for women Veterans June 11 at the Freedom ... Reporter Karin Johnson will be the emcee. , This ... and devotion to the nation. The banquet is free ...
(Date:5/27/2015)... Phoenix, Arizona (PRWEB) May 27, 2015 ... use of their advanced programmatic marketing technology, they have ... provides advertising support on a regional level for seven ... Honda's marketing was through television and radio media. In ... and, with the help of Genius Monkey , ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 With InnerVoice ... communication environment where the message is not only heard but ... drawing, or virtually any motivating image. This award-winning and affordable ... offer. , Now, using InnerVoice Sender app ... be sent to a learner remotely for no additional cost. ...
(Date:5/27/2015)... Des Moines, Iowa (PRWEB) May 27, 2015 ... time ticking away, a poll conducted during the "ACA ... 200 webinar poll participants, 75% are currently in the ... a little over 15% were confidently prepared for the ... that was shown during the webinar, those who are ...
Breaking Medicine News(10 mins):Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... understanding of what causes reading disabilities , , WEDNESDAY, April ... complete, real words are located in the brain,s visual ... published in the April 30 issue of Neuron ... may help improve understanding of reading disabilities. , "Although ...
... National VA Research Week, themed "Turning Hope,into Reality." ... and,collaborators, as well as the Veterans who make ... With state-of-the-art electronic,records and close public and private ... Because most of its researchers also provide,clinical care ...
... HILL, N.J., April 29 Nuvilex, Inc. (OTC Bulletin Board: ... that it will advance the release of Citroxin to ... medical offices as well as other at risk institutions ... has proof of Citroxin,s effectiveness in eliminating swine influenza ...
... conferenceEPHRATA, Pa., April 29 Did you know ... breast cancer in Pennsylvania who are uninsured or underinsured? ... not aware of the program or how it can benefit ... Coalition (PBCC), in partnership with Senator Vince Hughes, is publicizing ...
... Sen. Gillibrand,s Bill Directs Cosmetic Industry to Clean Up ... Gillibrand (D-N.Y.) took action to protect children,s health by ... Federal Drug Administration to investigate and regulate hazardous contaminants ... children.Gillibrand introduced the bill in response to a study ...
... as the lead organizational and strategic planning consultant. Led by General ... of the new healthcare delivery organization. , ... (PRWEB) April 29, 2009 ... care hospital. The hospital will be part of a health village ...
Cached Medicine News:Health News:Imaging IDs Brain Neurons With Preference for Real Words 2Health News:MultiVu Video Feed: VA Research Week Offers Glimpse into Medicine's Future 2Health News:Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu 2Health News:Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu 3Health News:Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu 4Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:New Federal Legislation Targets Toxic Chemicals in Baby Bath Products 2
... First Stop absorbable collagen hemostat. FirstStop is ... handling and removal characteristics. It can easily ... fit the wound. FirstStop products are not ... peeled away after hemostasis is achieved. As ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... D-Stat Flowable Hemostat has a thick, ... application, such as vascular access sites ... is also used as an adjunct ... tissue tracts of femoral access sites ...
The D-Stat Radial hemostat band utilizes a compression band together with the active haemostatic material of the D-Stat to control surface bleeding....
Medicine Products: